Making Time for Treatment

Keeping up with your prescribed treatment can be hard when life gets busy. But every day matters. That’s because CF is always present, even when symptoms aren’t. So find a treatment routine that works for your child and stick to it. You may feel stressed trying to stay on top of treatment. But your support and effort are invaluable.

When it comes to treating CF, taking Pulmozyme and other therapies as prescribed by your doctor can help improve lung function and reduce the risk for respiratory tract infection.

Using Pulmozyme along with standard therapies your doctor has prescribed may help your child. Your doctor may have prescribed your child multiple therapies for treating CF. Sticking with your doctor's prescribed treatment plan is important for your child's health. During Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and short-lived.

The Pulmozyme web site has many videos that may help you understand the science of CF and how Pulmozyme works to fight it.

Keep in mind that taking Pulmozyme means using a nebulizer. Nebulizers aren’t all the same. Some will make treatment go a little quicker, and some might have different cleaning directions. You should ask your CF Care Team to explain which is the most appropriate for your treatment as approved by the Food and Drug Administration.

Managing every aspect of CF may make a big difference for your child.

You can do things to help make their prescribed treatment a little easier for you and your child. For example, during treatment you can:

  • Show a movie

  • Read stories

  • Plan something fun, like a vacation

  • Involve your child by letting them hold the nebulizer or help clean it

  • Use an extra mask so your child can “give treatment” to a doll or stuffed animal

Indication and Usage

Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.

Important Safety Information

  • Pulmozyme should not be used in patients who are allergic to any of its ingredients

  • Pulmozyme should be used along with standard therapies for cystic fibrosis

  • When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose

  • These side effects are usually mild and short-lived

  • The effect of Pulmozyme on exercise tolerance has not been established in adults and children

For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.